World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Government agencies and non-profits at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
6 government agencies and non-profits are at World CDx 2026 — 7 presentations on the program. Most represented: Rare New England (2 on the program), BLOODPAC (1 on the program), Crohn's & Colitis Foundation (1 on the program). 1 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–6 of 6 organizations
| Organization | World CDx 2026 Attendance |
|---|---|
Rare New England Attleboro, MA | |
Massachusetts non-profit that supports and educates New England families, patients and clinicians dealing with rare and complex conditions, and works on regional policy. | Talk Wed Oct 7 4:40pm Rare New England’s Broad Role in Community & Policy Drug–diagnostic commercialization & access |
Non-profit consortium of industry, academia and regulators building shared data and standards to speed development and validation of liquid biopsy assays. | Panel Tue Oct 6 3:40pm Liquid Biopsy at the Point of Care: Making ctDNA Actionable for Treatment Selection Liquid biopsy & MRD Panel Tue Oct 6 6:10pm Strengthening Tumor‑Informed MRD Assays with Standardized Analytical Validation to Ensure Reliable Detection & Confident Clinical Interpretation Liquid biopsy & MRDClinical & companion diagnostic development |
Crohn's & Colitis Foundation New York, NY | |
Non-profit funding research, patient support and education for Crohn's disease and ulcerative colitis. | Talk Wed Oct 7 12:40pm MRD in IBD? Building a Precision Medicine Consortium for Deeper Endpoints in IBD Biomarker discovery & translation |
Friends of Cancer Research Washington, DC | |
Non-profit cancer research advocacy group that convenes industry, government and patient groups on regulatory and science policy. | Panel Wed Oct 7 12:10pm Building the Clinical & Commercial Ecosystem for AI-Enabled Precision Pathology Digital pathology & spatial biomarkersDrug–diagnostic commercialization & access |
Rare Cancer Research Foundation Durham, NC | |
Non-profit running Pattern.org, through which rare cancer patients donate tissue and data to research, plus a patient biobank and an open data commons. | Talk Thu Oct 8 12:20pm Integrated Multi-Omic Analysis as a Model for Precision Oncology Discovery Biomarker discovery & translationMultimodal & AI-enabled precision medicine |
Non-profit funding rare cancer research and sponsoring TRACK, a decentralized precision medicine trial that profiles tumors and matches patients with rare cancers to treatments. | Talk Thu Oct 8 9:20am On the Right TRACK: Building a Patient Driven, Decentralized Precision Medicine Trial in Rare Cancers Clinical & companion diagnostic development |
Instantly find 20 buyers from government agencies and non-profits
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World CDx 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction